Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

19-Sep-22 - 17-Sep-23
Buy Ratio:42%

Up

# Net Buyers:31
# Net Sellers:42

Previous 52 Weeks

20-Sep-21 - 18-Sep-22
Buy Ratio:30%
# Net Buyers:61
# Net Sellers:141
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals, Inc.--$532.47M  
Catalent, Inc.--$417.58M  
Eli Lilly & Co--$335.40M  
Chemocentryx, Inc.--$161.73M  
Dicerna Pharmaceuticals Inc--$132.05M  
New Net Buyers
CompanyNet Buy AmountChange
Abbvie Inc.$886.03K$65.28M  
Acadia Pharmaceuticals Inc$5.37M$5.66M  
Neurocrine Biosciences Inc$545.95K$4.76M  
Iveric Bio, Inc.$146.49K$3.61M  
Gilead Sciences, Inc.$1.18M$2.36M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Incyte Corp$5.64M($113.02M)  
Armata Pharmaceuticals, Inc.--($49.00M)  
Johnson & Johnson($29.30M)($24.31M)  
Horizon Therapeutics Public Ltd Co--($9.51M)  
Ani Pharmaceuticals Inc($9.21M)($9.39M)  
New Net Sellers
CompanyNet Buy AmountChange
Ani Pharmaceuticals Inc($9.21M)($9.39M)  
Galectin Therapeutics Inc($98.54K)($421.98K)